Features | Partner Sites | Information | LinkXpress
Sign In
AMPRONIX
SCHILLER AG
TERARECON, INC.

MR Elastography Detects Pediatric Liver Disease Without Need for Needle Biopsy

By Medimaging International staff writers
Posted on 03 Oct 2013
Magnetic resonance elastography (MRE), noninvasive imaging technique, can now help physicians effectively identify fibrosis in children with chronic liver disease, a growing problem caused partly by the increase of obesity rates.

The new study revealed that MRE detects such chronic diseases as nonalcoholic fatty liver disease (NAFLD), which is increasingly common in children and teens, affecting an estimated 13% of adolescents. NAFLD can lead to progressive liver disease and liver failure. Obesity is a major risk factor. “Because many pediatrics patients in the United States with NAFLD are severely obese, MRE is likely to be superior to ultrasound-based elastography in this population, as ultrasound-based methods are less reliable in severely obese patients,” stated Stavra Xanthakos, MD, a gastroenterologist at Cincinnati Children’s Hospital Medical Center (OH, USA), and lead author of the study.

The study was published online September 23, 2013, in the Journal of Pediatrics. If the findings are confirmed in larger studies, MRE could lessen dependence on expensive and invasive liver biopsies to detect fibrosis. The researchers, in 2011 and 2012, evaluated 35 children and teenagers between the ages of 4 and 20 for chronic liver disease employing both liver biopsy and MRE. The study demonstrated that MRE was highly accurate in detecting more advanced fibrosis in children with chronic liver disease, including severely obese patients.

A needle biopsy is standard practice for assessing liver fibrosis. This not only has risks for the patient and high expense, but it is frequently quite scary for children and teens. MRE is a way to gauges tissue stiffness that uses low frequency sound waves in combination with magnetic resonance, which involves the combination of magnetic fields and radio frequency waves to generate diagnostic images. MRE can be accomplished in just a few minutes using the MR scanner.

“Having the ability to easily and noninvasively assess the degree of fibrosis in a child's liver could help us identify the issue early and being the right course of treatment in a timely and effective manner,” noted Daniel Podberesky, MD, chief of thoracoabdominal imaging at Cincinnati Children's and a coauthor of the study. “An added strength of magnetic resonance technology is the ability to more precisely measure liver fat, which allows us to noninvasively determine changes in liver fat quantity after clinical interventions.”

“Our results show the exciting potential of MRE to improve clinical care and reduce dependence on liver biopsies, but it is not yet ready for primetime clinical use,” added Dr. Xanthakos. “In addition to validation in larger pediatric cohorts, we still need to determine whether MRE can predict changes in liver disease over time. We hope to study MRE in patients to test how well changes in imaging correlate with changes in liver stiffness after treatment or lifestyle changes.”

Dr. Xanthakos codirects the Cincinnati Children’s Steatohepatitis Center. Steatohepatitis is an advanced stage of fatty liver disease. In all, physicians at Cincinnati Children’s have effectively evaluated more than 200 children using liver MRE with no adverse events.

Related Links:

Cincinnati Children’s Hospital Medical Center



SuperSonic Imagine
RTI ELECTRONICS AB
RADCAL

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

Ultrasound

view channel
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.